Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...

Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...

The care of immunocompromised adults with acute respiratory failure (ARF) remains one of the greatest challenges of intensive care medicine.1 Management of these patients is challenging because ...

In this large international cohort of immunocompromised patients with ARF, we identified key risk and protective factors for mortality and intubation. These findings could improve outcomes by ...

A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the ...

The FDA has approved GSK's Arexvy for adults aged 18 to 49 who have increased risk of complications from the virus.

Experts warn of ‘attack on Americans’ lungs’ from cuts to health programs, environmental rollbacks and other plans ...

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...

OSA is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse during sleep.

Severe acute pancreatitis is frequently complicated by hospital-acquired infections that worsen outcomes and prolong intensive care stays. New evidence suggests that modulating the microbiome may ...

Dyne Therapeutics is plotting an approval application for z-rostudirsen in the back half of 2026—a push that will only be bolstered by the departure of controversial CBER chief Vinay Prasad, according ...

Real-world community study finds Enhertu in HER2-low metastatic breast cancer has trial-like discontinuation rates; ILD ...